Fennec Pharmaceuticals Inc. (FENC)
NASDAQ: FENC · Real-Time Price · USD
6.65
+0.05 (0.76%)
Feb 21, 2025, 4:00 PM EST - Market closed
Fennec Pharmaceuticals Employees
Fennec Pharmaceuticals had 29 employees as of December 31, 2023. The number of employees decreased by 7 or -19.44% compared to the previous year.
Employees
29
Change (1Y)
-7
Growth (1Y)
-19.44%
Revenue / Employee
$1,701,655
Profits / Employee
-$39,069
Market Cap
182.68M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
FENC News
- 15 days ago - Fennec Pharmaceuticals Announces Commercial Launch of PEDMARQSI® In Germany - GlobeNewsWire
- 2 months ago - Fennec Pharmaceuticals Announces Pedmarqsi® Positive Recommendation by NICE for the Prevention of Cisplatin-Induced Hearing Loss in England and Wales - GlobeNewsWire
- 2 months ago - Fennec Pharmaceuticals Announces Early Partial Repayment of Its Outstanding Convertible Debt Facility with Petrichor Healthcare Capital Management - GlobeNewsWire
- 2 months ago - Fennec Pharmaceuticals to Participate in Upcoming Investor Conference - GlobeNewsWire
- 3 months ago - Fennec Pharmaceuticals Inc. (FENC) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Fennec Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 4 months ago - Fennec Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024 - GlobeNewsWire
- 4 months ago - Fennec Pharmaceuticals Strengthens Executive Leadership Team with Three Key Appointments to Accelerate the Company's Next Stage of Growth - GlobeNewsWire